Artificial intelligence for drug discovery: Are we there yet?

C Hasselgren, TI Oprea - Annual Review of Pharmacology and …, 2024 - annualreviews.org
Drug discovery is adapting to novel technologies such as data science, informatics, and
artificial intelligence (AI) to accelerate effective treatment development while reducing costs …

Deciphering the impact of genomic variation on function

Code of Conduct Committee (alphabetical by last name … - Nature, 2024 - nature.com
Our genomes influence nearly every aspect of human biology—from molecular and cellular
functions to phenotypes in health and disease. Studying the differences in DNA sequence …

A brain cell atlas integrating single-cell transcriptomes across human brain regions

X Chen, Y Huang, L Huang, Z Huang, ZZ Hao, L Xu… - Nature Medicine, 2024 - nature.com
While single-cell technologies have greatly advanced our comprehension of human brain
cell types and functions, studies including large numbers of donors and multiple brain …

Pharos 2023: an integrated resource for the understudied human proteome

KJ Kelleher, TK Sheils, SL Mathias, JJ Yang… - Nucleic acids …, 2023 - academic.oup.com
Abstract The Illuminating the Druggable Genome (IDG) project aims to improve our
understanding of understudied proteins and our ability to study them in the context of …

An open-source framework for end-to-end analysis of electronic health record data

L Heumos, P Ehmele, T Treis, J Upmeier zu Belzen… - Nature medicine, 2024 - nature.com
With progressive digitalization of healthcare systems worldwide, large-scale collection of
electronic health records (EHRs) has become commonplace. However, an extensible …

The Monarch Initiative in 2024: an analytic platform integrating phenotypes, genes and diseases across species

TE Putman, K Schaper, N Matentzoglu… - Nucleic acids …, 2024 - academic.oup.com
Bridging the gap between genetic variations, environmental determinants, and phenotypic
outcomes is critical for supporting clinical diagnosis and understanding mechanisms of …

A review of biomedical datasets relating to drug discovery: a knowledge graph perspective

S Bonner, IP Barrett, C Ye, R Swiers… - Briefings in …, 2022 - academic.oup.com
Drug discovery and development is a complex and costly process. Machine learning
approaches are being investigated to help improve the effectiveness and speed of multiple …

Dynamic retrieval augmented generation of ontologies using artificial intelligence (DRAGON-AI)

S Toro, AV Anagnostopoulos, SM Bello… - Journal of Biomedical …, 2024 - Springer
Background Ontologies are fundamental components of informatics infrastructure in
domains such as biomedical, environmental, and food sciences, representing consensus …

Considerations for building and using integrated single-cell atlases

K Hrovatin, L Sikkema, VA Shitov, G Heimberg… - Nature …, 2024 - nature.com
The rapid adoption of single-cell technologies has created an opportunity to build single-cell
'atlases' integrating diverse datasets across many laboratories. Such atlases can serve as a …

A comprehensive study of the rare diseases and conditions targeted by orphan drug designations and approvals over the forty years of the Orphan Drug Act

LJ Fermaglich, KL Miller - Orphanet Journal of Rare Diseases, 2023 - Springer
Background Rare diseases affect more than 30 million Americans. The passage of the
Orphan Drug Act (ODA) in the United States in 1983 represented a launching point for a rare …